Inclusion Body Myositis
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Inclusion Body Myositis

What is the definition of Inclusion Body Myositis?
Inclusion body myositis (IBM) is a progressive muscle disorder characterized by muscle inflammation, weakness, and atrophy (wasting). It is a type of inflammatory myopathy. The most common symptoms include progressive weakness of the legs, arms, fingers, and wrists. Some people also have weakness of the facial muscles (especially muscles controlling eye closure), or difficulty swallowing (dysphagia). Muscle cramping and pain are uncommon, but have been reported in some people. The underlying cause of IBM is poorly understood and likely involves the interaction of genetic, immune-related, and environmental factors. Some people may have a genetic predisposition to developing IBM, but the condition itself typically is not inherited.
What are the alternative names for Inclusion Body Myositis?
  • Inclusion body myositis
  • IBM
  • Inflammatory myopathy
  • Sporadic inclusion body myositis
Who are the top Inclusion Body Myositis Local Doctors?
Elite in Inclusion Body Myositis
Elite in Inclusion Body Myositis
Referral required

Johns Hopkins Bayview Medical Center

4940 Eastern Avenue, Bayview Medical Offices, Level 01 (G), Clinic 5, Bayview Medical Offices, Level 01 (G), Clinic 5, 
Baltimore, MD 
Recognized by The Myositis Association
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Lisa Christopher is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Christopher is rated as an Elite provider by MediFind in the treatment of Inclusion Body Myositis. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis. Dr. Christopher is board certified in American Board Of Internal Medicine. Dr. Christopher is currently accepting new patients.

Elite in Inclusion Body Myositis
Neurology | Neuromusculoskeletal Medicine
Elite in Inclusion Body Myositis
Neurology | Neuromusculoskeletal Medicine
Referral may be required

UCI Health ALS & Neuromuscular Center

200 South Manchester Avenue, Suite 110, 
Orange, CA 
Recognized by The Myositis Association
Languages Spoken:
English
Offers Telehealth

Namita Goyal is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Orange, California. Dr. Goyal is rated as an Elite provider by MediFind in the treatment of Inclusion Body Myositis. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myositis, and Primary Lateral Sclerosis. Dr. Goyal is board certified in CA State Medical License 2012 - 2024 and MA State Medical License 2006 - 2023.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Inclusion Body Myositis
Elite in Inclusion Body Myositis
Referral may be required

Brigham And Womens Hospital

75 Francis St, 
Boston, MA 
Recognized by The Myositis Association
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Anthony Amato is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Amato is rated as an Elite provider by MediFind in the treatment of Inclusion Body Myositis. He is also highly rated in 63 other conditions, according to our data. His clinical expertise encompasses Inclusion Body Myositis, Myositis, Polymyositis, Thymectomy, and Gastrostomy. Dr. Amato is board certified in Neurology, 1991 and Neuromuscular Medicine, 2008. Dr. Amato is currently accepting new patients.

What are the latest Inclusion Body Myositis Clinical Trials?
Blocking Interferon-γ by Ruxolitinib for Treating Inclusion Body Myositis: a Phase IIb Trial

Summary: Refer to the Detailed Description section.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis

Summary: To evaluate the efficacy of Pozelimab/Cemdisiran combination therapy in patients with sIBM

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center